Related Experiment Video

Updated: Sep 26, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

[From risk factors to symptomatic coronary artery disease. Update cardiology 2001/2002--part I]

Roland Fries1, Michael Böhm

  • 1Medizinische Klinik und Poliklinik, Innere Medizin III, Kardiologie/Angiologie, Universitätskliniken des Saarlandes, Hamburg/Saar. fries@med-in.uni-saarland.de

Medizinische Klinik (Munich, Germany : 1983)
|April 26, 2003
PubMed

Insights

Advances in cardiovascular disease management are detailed, covering prevention, diagnostics, and treatments for atherosclerosis, myocardial infarction, and heart failure. Key areas include statins, hypertension drugs, angiography, revascularization, and acute myocardial infarction therapies.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Preventive Cardiology

Background:

  • The cardiovascular continuum links risk factors to atherosclerosis, acute events like myocardial infarction, and heart failure.
  • Significant progress has been made in cardiovascular disease prevention, diagnostics, and treatment.

Purpose of the Study:

  • To review recent advances in the management of the cardiovascular continuum.
  • To detail progress in cardiovascular disease prevention, noninvasive diagnostics, and revascularization.
  • To discuss new therapeutic options for acute myocardial infarction.

Main Methods:

  • Review of current literature and clinical studies.
  • Analysis of data on primary and secondary prevention strategies.
  • Evaluation of diagnostic techniques like magnetic resonance angiography.
  • Assessment of interventional and surgical revascularization methods.
  • Examination of therapeutic interventions for acute myocardial infarction.

Main Results:

  • Statins, antiplatelet agents, and vitamins play key roles in cardiovascular disease prevention.
  • The LIFE study compared losartan and atenolol in hypertension management.
  • Magnetic resonance angiography shows promise for detecting coronary stenoses.
  • Coronary revascularization strategies are evaluated for elderly patients and with sirolimus-eluting stents.
  • Glycoprotein IIb/IIIa inhibitors and low molecular weight heparin demonstrate efficacy in acute myocardial infarction.

Conclusions:

  • Comprehensive management across the cardiovascular continuum is crucial.
  • Advances in prevention, diagnostics, and therapeutics continue to improve cardiovascular outcomes.
  • Personalized approaches, considering patient factors and specific interventions, are essential.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...